Amagma Therapeutics is a startup biotechnology company founded by proven serial entrepreneurs including Prof. Tillman Gerngross and Prof. Leonard Zon.  Amagma scientists are working on the discovery and development of antibody therapeutics against inflammatory diseases (with a focus on GI disorders) which have proven intractable by other approaches.  Amagma is based in Waltham, Massachusetts, and funded by private investors including Polaris Partners.

Amagma Therapeutics

Senior Scientist, Protein Biochemistry

Scientist

PHD Graduate Student

Teaching Assistant

Undergraduate Research Assistant

Senior Scientist

Senior Research Associate

Research Associate III

Mimecast

Outlook

Microsoft Office 365

Mobile Friendly

WordPress.org

Google AdSense

Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades.  Sana is building differentiated capabilities across the spectrum of cell and gene therapy.  Three aspirations drive Sana as we look to discover treatments for patients with poor outcomes or currently untreatable diseases. The first is the ability to repair and control the genes in any cell in the body.  We are advancing novel delivery technologies with the goal of being able to deliver any payload to any cell in a specific, predictable, and repeatable manner, paving the way for next-generation in vivo gene therapy. Next is the ability to differentiate pluripotent stem cells ex vivo into immune-cloaked functional cells with the aspiration of being able to replace any missing or damaged cells in the body. Last is a belief we can enable broader access to our therapies through focusing on scalable manufacturing solutions, the cost of manufacturing, and aligning with key stakeholders. Sana launched in early 2019 and has over 350 employees in Seattle, Cambridge, and South San Francisco. Sana was founded with the long view – bringing together great people and the best technologies to deliver on the challenging promise of using engineered cells to meaningfully change the outcome of many human diseases.

Senior Scientist, Translational Sciences BioA

Contracts Manager

Principal Research Associate, Translational Sciences BioA

Principal Research Associate, Immunoassay Method Development

Sana Biotechnology, Inc.

Amazon SES

ServiceNow

CloudFlare Hosting

Atlassian Cloud

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom.

Manager, Clinical Data Management

CRISPR Therapeutics

Google Cloud Hosting

Google Tag Manager

Google Analytics

Biogen is a Massachusetts-based biotechnology company that researches and develops novel therapies for the treatment of neurological diseases across the globe.

Snr Manager, Feasibility

Manufacturing Specialist III, MFG Tech Ops

Sr. Reliability Engineer I

Neurology Account Specialist- Northern New England

Biogen

Amazon CloudFront

Route 53

Amazon Elastic Load Balancer

Amazon AWS

NetSuite

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people's lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Todd Borland

Scientist at Amagma Therapeutics

Todd Borland's Professional Contact Details

Todd Borland's Current Company Details

Amagma Therapeutics

Todd Borland's Work History and Education

Others Named Todd Borland

Frequently Asked Questions about Todd Borland

What company does Todd Borland work for?

What is Todd Borland's role at Amagma Therapeutics?

What is Todd Borland's email address?

What is Todd Borland's business email address?

What is Todd Borland's HQ phone number?

What industry does Todd Borland work in?

Who are Todd Borland's colleagues?

Colleagues at Amagma Therapeutics

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?